May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Patient and Ophthalmologist Attitudes (Views) Concerning Compliance and Dosing in Glaucoma Treatment
Author Affiliations & Notes
  • W.C. Stewart
    Pharmaceutical Research Network, LLC, Charleston, SC, United States
  • A.G. Konstas
    University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece
  • N. Pfeiffer
    Johannes Gutenberg-Universität Mainz, Mainz, Germany
  • Footnotes
    Commercial Relationships  W.C. Stewart, Pharmacia R; A.G.P. Konstas, None; N. Pfeiffer, None.
  • Footnotes
    Support  This study was sponsored by a grant from Pharmacia.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 97. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.C. Stewart, A.G. Konstas, N. Pfeiffer; Patient and Ophthalmologist Attitudes (Views) Concerning Compliance and Dosing in Glaucoma Treatment . Invest. Ophthalmol. Vis. Sci. 2003;44(13):97.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To identify research avenues that, by modifying physician practice, potentially might improve patient compliance. Methods: We interviewed 250 patients and 250 physicians via telephone in France, United Kingdom, Italy, Spain and Germany. The results of the surveys were compiled and evaluated by two independent physicians. Results: This study showed that most physicians believed that reduction of intraocular pressure is useful, although this appeared most important in the United Kingdom (96%), France (94%) and Spain (80%) compared to Italy (72%) and Germany (70%)(P < 0.0001). The majority of physicians believed that noncompliance exists in 0-25% of patients, whereas 34% of patients admitted to noncompliance, most often missing two doses within the previous month. Physicians believed patients would prefer once daily dosing (92%), and that this would help compliance, whereas 60% of patients preferred once daily dosing but only about 20% of patients believed it would assist compliance. Ninety-four percent of physicians believed that noncompliance could lead to visual loss, and while this information concerned most physicians (94%), this was less likely in Germany (52%)(P < 0.0001). Most patients had received information concerning daily dosing of their medicines (79%), and accordingly waited an average of 10 minutes between doses. However, only half had been told to wait at least five minutes between instilling two preparations. Approximately two-thirds of patients knew that missing medicines could cause visual loss. Most patients were unaware of patient oriented glaucoma associations. Conclusions: This study suggests that once daily dosing to increase patient satisfaction and dosing convenience, as well as providing patient education, potentially are clinical techniques that could increase compliance.

Keywords: clinical (human) or epidemiologic studies: tre • drug toxicity/drug effects • intraocular pressure 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.